169 related articles for article (PubMed ID: 22028623)
21. CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells.
Widemann A; Sabatier F; Arnaud L; Bonello L; Al-Massarani G; Paganelli F; Poncelet P; Dignat-George F
J Thromb Haemost; 2008 May; 6(5):869-76. PubMed ID: 18284598
[TBL] [Abstract][Full Text] [Related]
22. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets.
Strijbos MH; Kraan J; den Bakker MA; Lambrecht BN; Sleijfer S; Gratama JW
Cytometry B Clin Cytom; 2007 Mar; 72(2):86-93. PubMed ID: 17252604
[TBL] [Abstract][Full Text] [Related]
23. Large platelets but not putative endothelial progenitor cells are associated with low strut coverage after drug-eluting stent implantation.
Nührenberg TG; Zhao M; Stratz C; Amann M; Valina CM; Gick M; Trenk D; Binder H; Büttner HJ; Neumann FJ
Int J Cardiol; 2015 Nov; 199():358-65. PubMed ID: 26247791
[TBL] [Abstract][Full Text] [Related]
24. Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.
DuBois SG; Stempak D; Wu B; Mokhtari RB; Nayar R; Janeway KA; Goldsby R; Grier HE; Baruchel S
Pediatr Blood Cancer; 2012 Feb; 58(2):181-4. PubMed ID: 21319292
[TBL] [Abstract][Full Text] [Related]
25. A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer.
Sahora K; Schindl M; Kuehrer I; Eisenhut A; Werba G; Brostjan C; Telek B; Ba'ssalamah A; Stift J; Schoppmann SF; Gnant M
Anticancer Res; 2014 May; 34(5):2377-84. PubMed ID: 24778046
[TBL] [Abstract][Full Text] [Related]
26. Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer.
Ramcharan KS; Lip GY; Stonelake PS; Blann AD
Br J Cancer; 2014 Oct; 111(9):1742-9. PubMed ID: 25211664
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
[TBL] [Abstract][Full Text] [Related]
28. mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells.
Strijbos MH; van Krimpen BA; Debets R; Kraan J; Sleijfer S; Gratama JW; Lamers CH
Thromb Haemost; 2010 Aug; 104(2):318-26. PubMed ID: 20589320
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal markers on human adipose stem/progenitor cells.
Zimmerlin L; Donnenberg VS; Rubin JP; Donnenberg AD
Cytometry A; 2013 Jan; 83(1):134-40. PubMed ID: 23184564
[TBL] [Abstract][Full Text] [Related]
30. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
Mancuso P; Gidaro A; Gregato G; Raveane A; Cremonesi P; Quarna J; Caccia S; Gusso L; Rusconi S; Giacomelli A; Cogliati C; Bertolini F
J Thromb Haemost; 2020 Oct; 18(10):2744-2750. PubMed ID: 32762140
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance).
Nixon AB; Pang H; Starr MD; Friedman PN; Bertagnolli MM; Kindler HL; Goldberg RM; Venook AP; Hurwitz HI;
Clin Cancer Res; 2013 Dec; 19(24):6957-66. PubMed ID: 24097873
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells.
Mund JA; Estes ML; Yoder MC; Ingram DA; Case J
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1045-53. PubMed ID: 22282356
[TBL] [Abstract][Full Text] [Related]
33. Enrichment of Circulating Endothelial Cells by CD34 Microbeads Followed by Enumeration Using Flow Cytometry.
Burylo AM; de Weger VA; Stuurman FE; Beijnen JH; Schellens JHM
Thromb Haemost; 2017 Dec; 117(12):2356-2368. PubMed ID: 29212123
[TBL] [Abstract][Full Text] [Related]
34. A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?
Ko AH; Dito E; Schillinger B; Venook AP; Xu Z; Bergsland EK; Wong D; Scott J; Hwang J; Tempero MA
Invest New Drugs; 2008 Oct; 26(5):463-71. PubMed ID: 18379729
[TBL] [Abstract][Full Text] [Related]
35. Circulating endothelial cell kinetics and their potential predictive value during mobilization procedure.
Szmigielska-Kapłon A; Krawczyńska A; Czemerska M; Pluta A; Cebula-Obrzut B; Szmigielska K; Smolewski P; Robak T; Wierzbowska A
J Clin Apher; 2013 Oct; 28(5):341-8. PubMed ID: 23681977
[TBL] [Abstract][Full Text] [Related]
36. Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
Vroling L; van der Veldt AA; de Haas RR; Haanen JB; Schuurhuis GJ; Kuik DJ; van Cruijsen H; Verheul HM; van den Eertwegh AJ; Hoekman K; Boven E; van Hinsbergh VW; Broxterman HJ
Angiogenesis; 2009; 12(1):69-79. PubMed ID: 19212818
[TBL] [Abstract][Full Text] [Related]
37. Imaging flow cytometry for morphologic and phenotypic characterization of rare circulating endothelial cells.
Samsel L; Dagur PK; Raghavachari N; Seamon C; Kato GJ; McCoy JP
Cytometry B Clin Cytom; 2013; 84(6):379-89. PubMed ID: 23554273
[TBL] [Abstract][Full Text] [Related]
38. A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma.
Luo YH; Tseng PC; Lee YC; Perng RP; Whang-Peng J; Chen YM
Cancer Biomark; 2016; 16(1):19-29. PubMed ID: 26484608
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotyping of a Stromal Vascular Fraction from Microfragmented Lipoaspirate Used in Osteoarthritis Cartilage Treatment and Its Lipoaspirate Counterpart.
Polancec D; Zenic L; Hudetz D; Boric I; Jelec Z; Rod E; Vrdoljak T; Skelin A; Plecko M; Turkalj M; Nogalo B; Primorac D
Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31234442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
